Apple v Everybody

In the past couple years, demand has gone wild for drugs like Ozempic – and its cousins, Zepbound, Wegovy, and Mounjaro. For people who had never been able to lose weight before, suddenly the numbers on the scale were plummeting. And everybody wanted to get their hands on them. N ... Show More

Tariffs are the favorite tool of our current president, but there are lots of other ways that governments insert themselves into the free exchange of goods and services. Some of these trade barriers are so insidious and have been going on for so long that it may surprise you that ... Show More

For most Americans, we just lived through the highest period of inflation in our lives. And we are reminded of this every time we go grocery shopping. All over TikTok, tons of people have posted videos of how little they got for… $20. $40. $100. Most upsetting to us: an $8 box of ... Show More

Nilay and Dieter talk with Verge senior reporter Adi Robertson and senior editor Tom Warren about the first week of the Epic Games v Apple trial. Why Epic is burning its own cash to cook Apple Apple antitrust trial kicks off with Tim Sweeney’s metaverse dreams The Epic Games v. A ... Show More

The Verge's David Pierce, Alex Cranz, Lauren Feiner and Nilay Patel discuss the breaking news about the the US Department of Justice accusing Apple of operating an illegal monopoly in the smartphone market in an expansive new antitrust lawsuit. Further reading: US v. Apple: every ... Show More

The Apple chief executive took the stand in the Apple-Epic Games trial, which ended its third week and goes to closing arguments next weekSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info. 

Apple is facing pressure from regulatory agencies around the world to allow developers to use payment systems outside of Apple's own. You could say the battle with Epic is where that got started. See omnystudio.com/listener for privacy information. 

Our anchors kick off this Friday morning with all the details on Affirm’s earnings boosting the stock over 20 percent this morning. Then, Angel Investor Jason Calacanis joins to share his thoughts on the buy now, pay later trend, the SEC targeting Coinbase and much more. Also, it ... Show More

Bloomberg's Caroline Hyde and Ed Ludlow bring full coverage of Apple's product launch from Apple Park as the company faces internal chip delays, restrictions in China and a shifting supply chain. Plus, a look at Google's biggest antitrust challenge yet. See omnystudio.com/listene ... Show More